Richter closes another strong quarter, here is the new flash report

Hardly any faults with the Hungarian pharma company

Hungarian gov't aims to outsource the pharmaceutical supply of public hospitals

Into a single giant company.

Hungary's latest drug tax hike could make life miserable for millions

We have learned that Viktor Orbán has also received a plea on the matter

Richter reaches agreement to market new gynecological product

With Mithra Pharmaceuticals

Hungary Richter to report record revenue on weak forint

Analysts expect strong Q3 figures

Richter to expand use of its drug for therapeutic purposes

For women suffering from endometriosis

Richter to enter U.S. market with new drug

Signs license agreement with Hikma

EMA authorises new COVID treatment

Roche’s Roactemra helps ventilated patients

Hungry gov’t does away with yet another market

Online drug purchases to be outlawed

Hungary's Richter performs below expectations in Q1

No new record in sales this quarter

Hungary's Richter signs license and development agreement with Mycovia

For RVVC drug VT-1161

Richter, Hikma sign exclusive license agreement for Cariprazine

Hikma will supply the antipsychotic drug in the MENA region.

Hungarian pharma Richter withdraws pegfilgrastim marketing application

Negotiating the curves of the biosimilar scene.

Richter chief Bogsch discusses Q2 report

Hungary lowers price of 59 drugs

Hungary Richter has successful U.S. launch

Hungary Richter announces good news about Esmya

Hungary Richter lowers 2014 profit guidance on Russia-Ukraine crisis

Hungary drugmaker Richter buys company to gain foothold in Mexico

Hungary pharma Richter to enter Brazil market (2)